SPIEGELMAN DANIEL K

CIK 00012384035 companiesSAN RAFAEL, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001238403

Recent Transactions

42 trades

Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2015-06-05$122.30/sh−1,649→ 28,229 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2015-06-04$120.46/sh−1,801→ 29,878 total
Award
Anthera Pharmaceuticals Inc
Stock Option (right to buy)
2011-06-30+12,000→ 12,000 total
Award
Anthera Pharmaceuticals Inc
Stock Option (right to buy)
2011-06-30+12,000→ 12,000 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2011-06-12−2,076→ 0 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2011-06-12+2,076→ 20,885 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2011-06-12+2,076→ 20,885 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Units
2011-06-12−2,076→ 0 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2011-06-09+4,538→ 18,809 total
Award
Cascadian Therapeutics, Inc.
Common Stock
2011-06-09+4,538→ 18,809 total
Award
Anthera Pharmaceuticals Inc
Stock Option (right to buy)
2010-09-30+12,000→ 12,000 total
Award
Anthera Pharmaceuticals Inc
Stock Option (right to buy)
2010-09-30+12,000→ 12,000 total
Sale
CV THERAPEUTICS INC
Common Stock
2006-12-12$12.92/sh−3,000→ 3,439 total
Sale
CV THERAPEUTICS INC
Common Stock
2006-12-12$12.92/sh−3,000→ 3,439 total
Award
CV THERAPEUTICS INC
Restricted Stock Units
2006-12-11+20,000→ 20,000 total
Award
CV THERAPEUTICS INC
Restricted Stock Units
2006-12-11+20,000→ 20,000 total
Award
CV THERAPEUTICS INC
Nonstatutory Stock Option
2006-12-11+15,000→ 15,000 total
Award
CV THERAPEUTICS INC
Nonstatutory Stock Option
2006-12-11+15,000→ 15,000 total
Exercise/Conversion
CV THERAPEUTICS INC
Common Stock
2006-01-03+121→ 937 total
Exercise/Conversion
CV THERAPEUTICS INC
Stock Appreciation Right
2006-01-03−121→ 56,250 total
Tax Payment
CV THERAPEUTICS INC
Common Stock
2006-01-03$24.76/sh−51→ 886 total
Exercise/Conversion
CV THERAPEUTICS INC
Common Stock
2006-01-03+121→ 937 total
Tax Payment
CV THERAPEUTICS INC
Common Stock
2006-01-03$24.76/sh−51→ 886 total
Exercise/Conversion
CV THERAPEUTICS INC
Stock Appreciation Right
2006-01-03−121→ 56,250 total
Sale
CV THERAPEUTICS INC
Common Stock
2005-08-26$26.24/sh−21,506→ 0 total
Sale
CV THERAPEUTICS INC
Common Stock
2005-08-26$26.24/sh−21,506→ 0 total
Gift
CV THERAPEUTICS INC
Common Stock
2005-08-25−325→ 21,506 total
Gift
CV THERAPEUTICS INC
Common Stock
2005-08-25−325→ 21,506 total
Award
CV THERAPEUTICS INC
Common Stock, $0.001 par value per share ("Common Stock")
2005-01-24$19.31/sh+336→ 1,859.908 total
Award
CV THERAPEUTICS INC
Common Stock, $0.001 par value per share ("Common Stock")
2005-01-24$19.31/sh+336→ 1,859.908 total
Award
CV THERAPEUTICS INC
Restricted Stock Unit
2005-01-03+25,000→ 25,000 total
Award
CV THERAPEUTICS INC
Stock Appreciation Right
2005-01-03+75,000→ 75,000 total
Award
CV THERAPEUTICS INC
Restricted Stock Unit
2005-01-03+25,000→ 25,000 total
Award
CV THERAPEUTICS INC
Stock Appreciation Right
2005-01-03+75,000→ 75,000 total
Exercise/Conversion
CV THERAPEUTICS INC
Incentive Stock Option (right to buy)
2004-12-28+1,000→ 1,500 total
Exercise/Conversion
CV THERAPEUTICS INC
Common Stock
2004-12-28$9.00/sh+1,000→ 20,988 total
Exercise/Conversion
CV THERAPEUTICS INC
Incentive Stock Option (right to buy)
2004-12-28+1,000→ 1,500 total
Exercise/Conversion
CV THERAPEUTICS INC
Common Stock
2004-12-28$9.00/sh+1,000→ 20,988 total
Award
Bio Green Med Solution, Inc.$BGMS
Director Stock Option (Right to Buy)
2004-09-02+10,000→ 10,000 total
Award
Bio Green Med Solution, Inc.$BGMS
Director Stock Option (Right to Buy)
2004-09-02+10,000→ 10,000 total
Award
CV THERAPEUTICS INC
Common Stock, $0.001 par value per share ("Common Stock")
2004-01-13$14.67/sh+681.663→ 1,523.908 total
Award
CV THERAPEUTICS INC
Common Stock, $0.001 par value per share ("Common Stock")
2004-01-13$14.67/sh+681.663→ 1,523.908 total

Companies

Recent Filings

Address

C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO ST.

SAN RAFAEL, CA, 94901

View on SEC.gov